Berlin - Delayed Quote EUR

Viridian Therapeutics Inc (1S1.BE)

11.70 -0.70 (-5.65%)
At close: April 25 at 8:08 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
314.00
314.00
1,772.00
2,963.00
1,050.00
Operating Expense
254,764.00
254,764.00
136,076.00
82,691.00
41,569.00
Operating Income
-254,450.00
-254,450.00
-134,304.00
-79,728.00
-40,519.00
Net Non Operating Interest Income Expense
16,716.00
16,716.00
4,430.00
315.00
-335.00
Other Income Expense
--
--
--
--
-69,861.00
Pretax Income
-237,734.00
-237,734.00
-129,874.00
-79,413.00
-110,715.00
Net Income Common Stockholders
-237,734.00
-237,734.00
-129,874.00
-79,413.00
-110,715.00
Diluted NI Available to Com Stockholders
-237,734.00
-237,734.00
-129,874.00
-79,413.00
-110,715.00
Basic EPS
-5.14
-5.31
-4.05
-6.66
-31.13
Diluted EPS
-5.14
-5.31
-4.05
-6.66
-31.13
Basic Average Shares
42,451.85
44,755.48
32,087.29
11,918.71
3,557.07
Diluted Average Shares
42,451.85
44,755.48
32,087.29
11,918.71
3,557.07
Total Operating Income as Reported
-254,450.00
-254,450.00
-134,304.00
-79,728.00
-110,380.00
Total Expenses
254,764.00
254,764.00
136,076.00
82,691.00
41,569.00
Net Income from Continuing & Discontinued Operation
-237,734.00
-237,734.00
-129,874.00
-79,413.00
-110,715.00
Normalized Income
-237,734.00
-237,734.00
-129,874.00
-79,413.00
-40,854.00
Interest Income
18,563.00
18,563.00
4,916.00
318.00
173.00
Interest Expense
1,847.00
1,847.00
486.00
3.00
508.00
Net Interest Income
16,716.00
16,716.00
4,430.00
315.00
-335.00
EBIT
-235,887.00
-235,887.00
-129,388.00
-79,410.00
-110,207.00
EBITDA
-235,365.00
-235,365.00
-129,133.00
-79,290.00
-109,968.00
Reconciled Depreciation
522.00
522.00
255.00
120.00
239.00
Net Income from Continuing Operation Net Minority Interest
-237,734.00
-237,734.00
-129,874.00
-79,413.00
-110,715.00
Total Unusual Items Excluding Goodwill
--
--
--
--
-69,861.00
Total Unusual Items
--
--
--
--
-69,861.00
Normalized EBITDA
-235,365.00
-235,365.00
-129,133.00
-79,290.00
-40,107.00
12/31/2020 - 1/28/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OVID Ovid Therapeutics Inc.
2.9900
-5.08%
 
IMTX Immatics N.V.
9.78
-3.65%
 
ORIC ORIC Pharmaceuticals, Inc.
7.67
-5.07%
 
ERAS Erasca, Inc.
1.8800
0.00%
 
VRNA Verona Pharma plc
15.31
+0.46%
 
TSHA Taysha Gene Therapies, Inc.
2.3000
-2.13%